07 September 2018
A new report by visiongain predicts that the Global Generics Drugs market will reach $356.8bn in 2020. This forecast and others appear in Generic Drugs Market Forecast 2016-2026: Growth in Leading Regional and National Markets, published in April 2016. Visiongain is a business information provider based in London, UK.
This report examines the current and future trends in the growing generic drugs market. Population growth and changing demographics with increasing proportions of elderly people in most markets will enhance growth of the market. The rapid emergence of the middle-class in many emerging markets will also contribute to growth. Cost-pressures that encourage healthcare providers and governments to introduce policies to further encourage the use of generic drugs will further bring growth to the generics market over the years.
In this report, we examine in detail the global generic drugs market, and provide analyses and forecasts for regional and national markets. Historical revenues, where available, have also been added to strengthen our analysis and demonstrate how this market has changed. Qualitative analysis of the market is given, taking into account governmental policy and regulation, safety, features and more.
Visiongain’s report provides revenue forecasts to 2026 for the Generic Drugs market, including forecasts for leading regional and national markets: US, EU5 (Germany, UK, France, Italy and Spain), Asia-Pacific (China, Japan and India) as well as emerging markets (Brazil, Russia, Mexico, South Korea and Turkey). The report also discusses selected leading companies in the market. These companies include Teva, Mylan, Novartis (Sandoz), Sun Pharma, Pfizer, Abbott, Allergan, Fresenius Kabi, Sanofi and Aspen.
Generic Drugs Market Forecast 2016-2026: Growth in Leading Regional and National Markets adds to visiongain’s range of analytical reports on industries and markets in healthcare.
For an executive summary please contact:
Email: Sara Peerun on email@example.com
Tel: +44 (0) 20 7336 6100
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. From its head office in London, UK, visiongain produces a range of newsletters, business reports and e-zines covering current affairs and market trends in the Energy, Telecoms, Pharmaceutical, Defence, and Materials sectors.
Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high quality, original analyses to inform their strategic decisions.
The 431-page report provides clear detailed insight into the generic drugs market. Discover the key drivers and challenges affecting the market.
03 July 2020
Where is the Clinical Workflow Solutions market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.
03 July 2020
With the growing burden of rare diseases around the world, there has been a rise and advancement in the therapy development of these types of diseases. While the fact remains that over 90% of these diseases lack approval for treatment and the total number of terminal rare diseases to receive the first treatment every year remains low.
01 July 2020
The market growth is attributed to the growing adoption of big data and AI in data management and monitoring of clinical information in health care.